• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.

作者信息

Vollmer Olivier, Tacquard Charles, Dieudonné Yannick, Nespola Benoit, Sattler Laurent, Grunebaum Lélia, Gies Vincent, Radosavljevic Mirjana, Kaeuffer Charlotte, Hansmann Yves, Weber Jean-Christophe, Martin Thierry, Arnaud Laurent, Morel Olivier, Guffroy Aurélien, Collange Olivier, Mertes Paul Michel, Korganow Anne-Sophie, Delabranche Xavier, Poindron Vincent

机构信息

Service d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.

Service d'Anesthésie-Réanimation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

出版信息

Autoimmun Rev. 2021 Jun;20(6):102822. doi: 10.1016/j.autrev.2021.102822. Epub 2021 Apr 16.

DOI:10.1016/j.autrev.2021.102822
PMID:33872769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8050395/
Abstract
摘要

相似文献

1
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.新型冠状病毒肺炎患者的随访：狼疮抗凝物是短暂的，但其他抗磷脂抗体是持续存在的。
Autoimmun Rev. 2021 Jun;20(6):102822. doi: 10.1016/j.autrev.2021.102822. Epub 2021 Apr 16.
2
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.关于新冠病毒相关凝血病中抗磷脂抗体的现实核查
Arthritis Rheumatol. 2021 Jan;73(1):173-174. doi: 10.1002/art.41472. Epub 2020 Dec 5.
3
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature.狼疮抗凝物是否为 COVID-19 的重要特征？文献评价。
Semin Thromb Hemost. 2022 Feb;48(1):55-71. doi: 10.1055/s-0041-1729856. Epub 2021 Jun 15.
4
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre.抗磷脂抗体随时间的持续性及其与临床表现复发的关联：来自单一中心的纵向研究。
Autoimmun Rev. 2022 Dec;21(12):103208. doi: 10.1016/j.autrev.2022.103208. Epub 2022 Oct 3.
5
Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.系统性红斑狼疮患者中罕见抗磷脂/蛋白辅助因子自身抗体的鉴定
Autoimmunity. 2009 Sep;42(6):497-506. doi: 10.1080/08916930902882731.
6
[Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].[90例抗磷脂综合征患者的抗体滴度及其与临床表现的相关性：疾病症状、一种新抗体及其与以色列人群临床表现的相关性]
Harefuah. 2001 Jun;140(6):495-500, 565.
7
The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.β2糖蛋白I依赖性狼疮抗凝物在抗磷脂综合征发病机制中的作用
Verh K Acad Geneeskd Belg. 2000;62(5):353-72.
8
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.在感染 SARS-CoV-2 的孕妇中抗磷脂抗体阳性的频率及其对妊娠结局的影响：一项针对 151 例妊娠的单中心前瞻性研究。
Front Immunol. 2022 Sep 15;13:953043. doi: 10.3389/fimmu.2022.953043. eCollection 2022.
9
[Antiphospholipid antibodies: what is new in 2022].[抗磷脂抗体：2022年有哪些新进展]
Ann Biol Clin (Paris). 2022 Jul 1;80(4):333-343. doi: 10.1684/abc.2022.1745.
10
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.成人系统性红斑狼疮患者以外的抗磷脂抗体类型与静脉和动脉血栓形成风险：系统评价和荟萃分析。
Autoimmun Rev. 2014 Jun;13(6):595-608. doi: 10.1016/j.autrev.2013.11.004. Epub 2014 Jan 11.

引用本文的文献

1
The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.在患有肺炎和血管血栓形成的重症 COVID-19 病例中抗磷脂综合征的新出现可能解释 COVID 后综合征。
Biomedicines. 2025 Feb 19;13(2):516. doi: 10.3390/biomedicines13020516.
2
Antiphospholipid Antibodies and COVID-19: A Systematic Review of Clinical Implications.抗磷脂抗体与新型冠状病毒肺炎：临床意义的系统评价
Immun Inflamm Dis. 2025 Feb;13(2):e70134. doi: 10.1002/iid3.70134.
3
Persistent Lupus Anticoagulant Positivity and Long-Term Sequelae Following Mild COVID-19.

本文引用的文献

1
Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward.医学病房收治的新冠肺炎患者中的抗磷脂抗体与血栓形成事件
Autoimmun Rev. 2021 Feb;20(2):102729. doi: 10.1016/j.autrev.2020.102729. Epub 2020 Dec 13.
2
Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020.2020 年 3 月法国东北部 1045 例住院 COVID-19 患者的前瞻性分析：与严重 COVID-19 相关的临床特征和危险因素。
Euro Surveill. 2020 Dec;25(48). doi: 10.2807/1560-7917.ES.2020.25.48.2000895.
3
Severe COVID-19: A multifaceted viral vasculopathy syndrome.
轻度新冠病毒感染后狼疮抗凝物持续阳性及长期后遗症
Cureus. 2024 Oct 29;16(10):e72668. doi: 10.7759/cureus.72668. eCollection 2024 Oct.
4
Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review.抗磷脂抗体相关肝血管炎在非重症 COVID-19 后青少年中的发病：病例报告及文献复习。
Front Immunol. 2024 Apr 19;15:1354349. doi: 10.3389/fimmu.2024.1354349. eCollection 2024.
5
Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation.接受体外膜肺氧合的患者狼疮抗凝物的流行率和影响。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231207062. doi: 10.1177/10760296231207062.
6
Prevalence, clinical significance, and persistence of autoantibodies in COVID-19.新型冠状病毒肺炎患者自身抗体的流行率、临床意义和持续时间。
Virol J. 2023 Oct 16;20(1):236. doi: 10.1186/s12985-023-02191-z.
7
Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity.新冠病毒疾病急性期的血栓形成和过度炎症与抗磷脂酰丝氨酸和抗磷脂酰肌醇抗体阳性有关。
Biomedicines. 2023 Aug 18;11(8):2301. doi: 10.3390/biomedicines11082301.
8
Molecular mimicry and autoimmunity in the time of COVID-19.在 COVID-19 时代的分子模拟和自身免疫。
J Autoimmun. 2023 Sep;139:103070. doi: 10.1016/j.jaut.2023.103070. Epub 2023 Jun 12.
9
Evaluation of the Association between Antiphospholipid Antibodies and ICU Admission Outcome in Critically Ill COVID-19 Patients in Iranian Population.伊朗人群中重症 COVID-19 患者抗磷脂抗体与入住重症监护病房结局之间关联的评估
Int J Prev Med. 2022 Nov 23;13:140. doi: 10.4103/ijpvm.ijpvm_518_21. eCollection 2022.
10
COVID-19 and antiphospholipid antibodies.COVID-19 与抗磷脂抗体。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101402. doi: 10.1016/j.beha.2022.101402. Epub 2022 Oct 15.
严重 COVID-19：一种多方面的病毒性血管病综合征。
Ann Diagn Pathol. 2021 Feb;50:151645. doi: 10.1016/j.anndiagpath.2020.151645. Epub 2020 Oct 13.
4
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.COVID-19 住院患者血清中的促血栓形成自身抗体。
Sci Transl Med. 2020 Nov 18;12(570). doi: 10.1126/scitranslmed.abd3876. Epub 2020 Nov 2.
5
Lupus Anticoagulant in Patients with Covid-19. Reply.新冠病毒肺炎患者中的狼疮抗凝物。回复。
N Engl J Med. 2020 Nov 5;383(19):1893-1894. doi: 10.1056/NEJMc2027508. Epub 2020 Oct 23.
6
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突糖蛋白与哺乳动物蛋白质组之间的分子模拟：对疫苗的影响。
Immunol Res. 2020 Oct;68(5):310-313. doi: 10.1007/s12026-020-09152-6. Epub 2020 Sep 18.
7
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病（COVID-19）患者狼疮抗凝物阳性的评估
JAMA Netw Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539.
8
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?抗磷脂抗体与危重症 COVID-19 患者的血栓并发症有关吗？
Thromb Res. 2020 Nov;195:74-76. doi: 10.1016/j.thromres.2020.07.016. Epub 2020 Jul 8.
9
Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity.抗心磷脂IgG自身抗体水平是新冠病毒疾病严重程度的独立危险因素。
Arthritis Rheumatol. 2020 Nov;72(11):1953-1955. doi: 10.1002/art.41409. Epub 2020 Sep 22.
10
Covid-19 and autoimmunity.新冠病毒与自身免疫
Autoimmun Rev. 2020 Aug;19(8):102597. doi: 10.1016/j.autrev.2020.102597. Epub 2020 Jun 11.